Skip to main content
SpringerLink
Log in

Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Triptolide has been reported to exhibit antitumor effects in several cancers. This study investigates the mechanism by which triptolide induces apoptosis of gastric cancer cells. Gastric biopsies were collected for histological evaluation and detection of murine double minute 2 (MDM2) expression. Gastric cancer cells were cultured and treated with different concentrations of triptolide at indicated time points. The expression of MDM2, p53 protein, and target proteins including p21, PUMA, and X-linked inhibitor of apoptosis protein (XIAP) was detected. Apoptosis of cells treated with or without triptolide was evaluated. Our results showed that MDM2 protein was overexpressed in gastric cancer (p < 0.01, resp.). Triptolide induced significant apoptosis of gastric cancer cells in a dose- and time-dependent manner (p < 0.05). In addition, treatment with triptolide strongly inhibited the overexpression of MDM2 in gastric cancer cells, and this MDM2 inhibition led to increased levels of p53 protein and inhibition of XIAP (p < 0.05). However, triptolide failed to increase the expression of p53 target protein p21 and PUMA (p > 0.05). In conclusion, triptolide may induce apoptosis of gastric cancer cells via the inhibition of MDM2 overexpression in a p53-independent manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bollschweiler E, Berlth F, Baltin C, et al. Treatment of early gastric cancer in the Western World. World J Gastroenterol. 2014;20:5672–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Asombang AW, Rahman R, Ibdah JA. Gastric cancer in Africa: current management and outcomes. World J Gastroenterol. 2014;20:3875–9.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  4. Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011;60:1644–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Proserpio I, Rausei S, Barzaghi S, et al. Multimodal treatment of gastric cancer. World J Gastrointest Surg. 2014;6:55–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Honda R, Tanaka H, Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997;420:25–7.

    Article  PubMed  CAS  Google Scholar 

  7. Eischen CM, Lozano G. p53 and MDM2: antagonists or partners in crime? Cancer Cell. 2009;15:161–2.

    Article  PubMed  CAS  Google Scholar 

  8. Nakajima N, Ito Y, Yokoyama K, et al. The expression of murine double minute 2 (MDM2) on Helicobacter pylori-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr. 2009;44:196–202.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  9. Vazquez A, Bond EE, Levine AJ, et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov. 2008;7:979–87.

    Article  PubMed  CAS  Google Scholar 

  10. Shangary S, Wang S. Small-molecule inhibitors of the MDM2–p53 protein–protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol. 2009;49:223–41.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Huang M, Zhang H, Liu T, et al. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Mol Cancer Ther. 2013;12:184–94.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  12. Wang W, Yang S, Su Y, et al. Enhanced antitumor effect of combined triptolide and ionizing radiation. Clin Cancer Res. 2007;13:4891–9.

    Article  PubMed  CAS  Google Scholar 

  13. Mujumdar N, Mackenzie TN, Dudeja V, et al. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology. 2010;139:598–608.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Kitzen JJ, de Jonge MJ, Lamers CH, et al. Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours. Eur J Cancer. 2009;45:1764–72.

    Article  PubMed  CAS  Google Scholar 

  15. Zhu W, Ou Y, Li Y, et al. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol. 2009;75:812–9.

    Article  PubMed  CAS  Google Scholar 

  16. Phillips PA, Dudeja V, McCarroll JA, et al. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 2007;67:9407–16.

    Article  PubMed  CAS  Google Scholar 

  17. Chen G, Sordillo EM, Ramey WG, et al. Apoptosis in gastric epithelial cells induced by Helicobacter pylori and accompanied by increased expression of BAK. Biochem Biophys Res Commun. 1997;239:626–32.

    Article  PubMed  CAS  Google Scholar 

  18. Teodoro JG, Evans SK, Green MR. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome. J Mol Med (Berl). 2007;85:1175–86.

    Article  CAS  Google Scholar 

  19. Fridman JS, Lowe SW. Control of apoptosis by p53. Oncogene. 2003;22:9030–40.

    Article  PubMed  CAS  Google Scholar 

  20. Shangary S, Wang S. Targeting the MDM2–p53 interaction for cancer therapy. Clin Cancer Res. 2008;14:5318–24.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. Chang WT, Kang JJ, Lee KY, et al. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol Chem. 2001;276:2221–7.

    Article  PubMed  CAS  Google Scholar 

  22. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006;7:988–94.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Wang DG, Sun YB, Ye F, et al. Anti-tumor activity of the X-linked inhibitor of apoptosis (XIAP) inhibitor embelin in gastric cancer cells. Mol Cell Biochem. 2014;386:143–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the Center for Medical Experiment of Zhongnan Hospital of Wuhan University (Wuhan, China) for technical assistances.

Conflict of interest

The authors have declared that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of General Surgery, Zhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, 430071, Hubei, China

    Bo-Yong Wang, Jun Cao, Ji-Wei Chen & Quan-Yan Liu

Authors
  1. Bo-Yong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ji-Wei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Quan-Yan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jun Cao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, BY., Cao, J., Chen, JW. et al. Triptolide induces apoptosis of gastric cancer cells via inhibiting the overexpression of MDM2. Med Oncol 31, 270 (2014). https://doi.org/10.1007/s12032-014-0270-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0270-7

Keywords

Search

Navigation